Holen Sie sich die Stockscreener-App
318.13
1.38%
-4.46
Handel nachbörslich:
318.13
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LH?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$322.59
Offen:
$317.35
24-Stunden-Volumen:
436.23K
Relative Volume:
0.68
Marktkapitalisierung:
$25.80B
Einnahmen:
$14.14B
Nettoeinkommen (Verlust:
$942.70M
KGV:
28.19
EPS:
11.2856
Netto-Cashflow:
$1.38B
1W Leistung:
-0.33%
1M Leistung:
+15.40%
6M Leistung:
+12.56%
1J Leistung:
+17.28%
1-Tages-Spanne:
$317.06
$322.99
1-Wochen-Bereich:
$315.33
$325.58
52-Wochen-Spanne:
$244.52
$325.58
Labcorp Holdings Inc Stock (LH) Company Profile
Firmenname
Labcorp Holdings Inc
Sektor
Branche
Telefon
(336) 229-1127
Adresse
358 S MAIN ST, BURLINGTON, NC
Compare LH vs TMO, DHR, NTRA, IDXX, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
318.13 | 26.23B | 14.14B | 942.70M | 1.38B | 11.29 |
TMO
Thermo Fisher Scientific Inc
|
588.29 | 222.96B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
202.45 | 144.67B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
309.93 | 45.54B | 2.50B | -226.32M | 71.51M | -1.6412 |
IDXX
Idexx Laboratories Inc
|
550.96 | 44.95B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
148.53 | 41.87B | 7.23B | 1.41B | 1.09B | 4.979 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-04-02 | Eingeleitet | Redburn Atlantic | Buy |
| 2025-03-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-01-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-12-10 | Fortgesetzt | Jefferies | Buy |
| 2024-10-30 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-10-01 | Eingeleitet | Piper Sandler | Neutral |
| 2024-03-25 | Hochstufung | Argus | Hold → Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-09 | Eingeleitet | Evercore ISI | In-line |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2022-12-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-09-19 | Herabstufung | Argus | Buy → Hold |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-01-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-01-11 | Hochstufung | Argus | Hold → Buy |
| 2021-01-11 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2021-01-08 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-07-14 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-13 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | Fortgesetzt | Deutsche Bank | Buy |
| 2020-05-15 | Hochstufung | Mizuho | Neutral → Buy |
| 2020-04-29 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-04-27 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-04-27 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2019-07-16 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-06-21 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-04-02 | Hochstufung | Jefferies | Hold → Buy |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2019-01-03 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | Herabstufung | Craig Hallum | Buy → Hold |
| 2018-10-30 | Herabstufung | Argus | Buy → Hold |
| 2018-10-25 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2018-10-19 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-06-07 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-05-01 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2018-03-23 | Eingeleitet | Argus | Buy |
Alle ansehen
Labcorp Holdings Inc Aktie (LH) Neueste Nachrichten
Labcorp Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Labcorp Holdings (LH) Announces Leadership Transition in Biophar - GuruFocus
Form 8K Labcorp Holdings Inc For: 14 August By Investing.com - Investing.com Nigeria
Labcorp announces executive leadership changes effective in September - Investing.com
Labcorp Holdings Inc. (LH) Stock Price, News, Quote & History - ca.finance.yahoo.com
Labcorp CEO Adam H. Schechter Executes Sale of 4,669 Shares via Rule 10b5-1 Plan - Kalkine Media
Labcorp CEO Adam Schechter Sells 4,669 Shares for $1.5 Million - The Motley Fool
Labcorp CEO Adam Schechter Sells 4,669 Shares for $1.5 Million - The Motley Fool
Labcorp president & CEO Adam Schechter sells $1.5m in company stock - Investing.com India
Labcorp president & CEO Adam Schechter sells $1.5m in company stock By Investing.com - Investing.com Australia
Insider Selling: Labcorp (NYSE:LH) CEO Sells 4,669 Shares of Stock - MarketBeat
Labcorp Holdings Insider Sold Shares Worth $1,495,808, According to a Recent SEC Filing - marketscreener.com
Labcorp (LH) CEO Adam Schechter sells 4,669 shares at $320.37 under 10b5-1 plan - Stock Titan
Is Labcorp Holdings (LH) Fully Priced Following Oncology Approvals And Raised Outlook? - Yahoo Finance
Labcorp (NYSE:LH) Sets New 52-Week HighStill a Buy? - MarketBeat
Labcorp Holdings Inc. (NYSE:LH) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Labcorp Holdings Inc. Stock 12‑Month Price Target Raised to $345.79, Implies 7% Upside - TradingView
Did Stronger Guidance, Buybacks and New Oncology Tests Just Shift Labcorp Holdings' (LH) Investment Narrative? - Yahoo Finance
Insight Inv LLC's Labcorp Holdings Inc(LH) Holding History - GuruFocus
Adam Schechter (LH) files to sell 4,669 shares of common stock on NYSE - Stock Titan
Labcorp (LH) Short Interest & Short Float | Updated Aug 2026 $LH - MarketBeat
Is Labcorp Stock a Buy as Growth Improves but Valuation Stays Rich? - The Globe and Mail
Labcorp Wins FDA Approval for Melanoma Companion Diagnostic - marketscreener.com
Labcorp wins FDA approval for melanoma companion diagnostic By Investing.com - Investing.com Canada
For advanced melanoma, Labcorp's test supports access to targeted therapies - Stock Titan
Labcorp Holdings Inc. (LH) Stock Analysis: A Strong Buy with 5.82% Upside Potential and Robust Growth Prospects - DirectorsTalk Interviews
Assenagon Asset Management S.A. Increases Stake in Labcorp Holdings Inc. $LH - MarketBeat
Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma - Sahm
What Labcorp Holdings (LH)'s New PTEN Test and Guidance Hike Means For Shareholders - Sahm
Labcorp (LH) Q2 2026 Earnings Call Transcript - webull.com
Labcorp Holdings Inc (LH) Stock News Today - TradingKey
Labcorp Holdings stock hits all-time high at 317.29 USD By Investing.com - Investing.com Australia
Labcorp Holdings (LH) Could Be 4% Undervalued As Guidance Rises And New Tests Roll Out - Sahm
Labcorp Holdings stock hits all-time high at 317.29 USD - Investing.com
Labcorp Stock Jumps 14% in a Month as Growth Meets Rich Valuation - Yahoo Finance
Labcorp Holdings Inc (LH) EVP and Chief Marketing Officer Amy Su - GuruFocus
Labcorp EVP Amy Summy sells $283k in common stock By Investing.com - Investing.com Australia
Labcorp (NYSE:LH) Hits New 12-Month HighWhat's Next? - MarketBeat
Labcorp EVP Amy Summy sells $283k in common stock - Investing.com
Labcorp Holdings Insider Sold Shares Worth $283,428, According to a Recent SEC Filing - marketscreener.com
Labcorp (NYSE:LH) EVP Sells 924 Shares of Stock - MarketBeat
Labcorp Holdings (LH) EVP Amy Summy sells 924 common shares - Stock Titan
LABCORP HOLDINGS 2026: Revenue $3.73B, EPS $3.64— 10-Q Summary - TradingView
[10-Q] LABCORP HOLDINGS INC. Quarterly Earnings Report - Stock Titan
Labcorp Holdings (NYSE: LH) CAO sells 1,420 shares after exercising options - Stock Titan
Bank of America Corp DE Cuts Stake in Labcorp Holdings Inc. $LH - MarketBeat
Labcorp Holdings Inc. (LH) Stock forecasts - Yahoo Finance UK
Labcorp Holdings Inc. stock rises Tuesday, still underperforms market - MarketWatch
The Bull Case For Labcorp (LH) Could Change Following Guidance Hike And New Genetic Panel Launch - webull.com
Pacer Advisors Inc. Trims Stock Position in Labcorp Holdings Inc. $LH - MarketBeat
Labcorp Holdings Inc. $LH Shares Sold by The Manufacturers Life Insurance Company - MarketBeat
Finanzdaten der Labcorp Holdings Inc-Aktie (LH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):